Renal Physicians Association

Kidney Patients Honor Top Physician for Disease and Infection Prevention

Retrieved on: 
Monday, April 15, 2024
Education, FDA, Kidney disease, Medicine, Chronic kidney disease, Kidney, CDC, RPA, The Rogosin Institute, Society, Nursing, Optimism, Dialysis, Medal, Problem solving, Patient, NIH, Health, Nephrology, Research, World Neurosurgery, Retirement, CKD, Family, VHI, Medicare, Government, ESRD, Bangladesh Technical Education Board, Social work, Policy, MD, Renal Physicians Association, Science, Pharmaceutical industry

WASHINGTON, April 15, 2024 /PRNewswire/ -- The American Association of Kidney Patients (AAKP), America's oldest and largest independent kidney patient advocacy organization, awarded its 2024 Medal of Excellence Award in the Physician Category to Dr. Barry Smith, PhD, MD, President of New York-based Dreyfus Health Policy and Research Center. The AAKP announcement occurred during the 50th Anniversary Meeting of the Renal Physicians Association (RPA) in Baltimore, Maryland. 

Key Points: 
  • The RPA is a long-standing ally of the AAKP and is the professional organization of nephrologists whose goal is to ensure quality care under the highest standards of medical practice for patients with kidney disease and related disorders.
  • Dr. Smith was selected as a Physician Honoree based on his distinguished career spanning academia, government, and clinical care management and his dedicated efforts to expand patient engagement in infection prevention and medical innovation.
  • Dr. Smith is highly regarded for his focus on disease prevention through better community education on issues including food choices and nutrition as well infection prevention through improved safety measures and access to new safety innovations.
  • The Medal of Excellence includes award categories in transplant surgery, transplant professional, physician, nursing, dietitian, social work, and dialysis technician.

Dr. Lisandro Montalvo-Burke Joins Healthmap Solutions as Medical Director for Puerto Rico

Retrieved on: 
Tuesday, February 13, 2024
Private practice, Chronic kidney disease, Emergency, Psychology, National Kidney Foundation, MD, Medical director, University, Dialysis, Kidney disease, PR, CKD, Renal Physicians Association, Society, Sociedad, Morazán, Patient, ESRD, Nephrology, Hurricane Maria, Nursing

GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in Puerto Rico.

Key Points: 
  • GUAYNABO, Puerto Rico, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), a leading kidney population health management company, has named Lisandro Montalvo-Burke, MD as its new Medical Director in Puerto Rico.
  • Dr. Montalvo is a board-certified nephrologist and has been practicing nephrology in Canovanas, PR at his private practice since 2005.
  • He is a member of the American Society of Nephrology, Renal Physicians Association, National Kidney Foundation, and Sociedad de Nefrología e Hipertensión de Puerto Rico.
  • Healthmap has an all-star team here in Puerto Rico, and I am thrilled to be part of the organization.”

Moreno Valley Physicians Associates Empowers Patients and Improves Communication Through Integration with eClinicalWorks AI Tools

Retrieved on: 
Thursday, November 16, 2023
Software, Practice Management, Health, Artificial Intelligence, Data Management, Hospitals, Health Technology, Technology, EHR, Patient satisfaction, Language, Patient, Multimedia, Tears, Communication, Renal Physicians Association, AI, Physician, Travel, Medical device, Health insurance

eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Moreno Valley Physicians Associates (Moreno Valley) – a family medicine practice in Moreno Valley, CA – successfully implemented the new eClinicalWorks AI assistant tools to easily translate medical documentation in its patients’ native language within the EHR, improving care coordination, patient satisfaction, and communication.

Key Points: 
  • eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Moreno Valley Physicians Associates (Moreno Valley) – a family medicine practice in Moreno Valley, CA – successfully implemented the new eClinicalWorks AI assistant tools to easily translate medical documentation in its patients’ native language within the EHR, improving care coordination, patient satisfaction, and communication.
  • Without a way to easily translate visit summaries and lab results into Spanish, many patients were unable to fully understand their results.
  • “We had one patient who was over 60 and spoke no English,” said Esteban Guerrero, general manager of Moreno Valley.
  • AI tools – like our AI assistant tools – are the key to making that a reality today.”

Dr. Charmaine Lok and Dr. Allen R. Nissenson Join PatenSee's Scientific Advisory Board

Retrieved on: 
Wednesday, September 20, 2023
Ottawa Hospital Research Institute, David Geffen School of Medicine at UCLA, National Kidney Foundation, Rockwell Medical, Kidney failure, University, Emeritus, Stenosis, Teaching, Physician, Renal replacement therapy, Coronavirus Scientific Advisory Board, Research, Mentorship, Associate, University Health Network, Dialysis, ASN, Patient, NKF, Nursing, DaVita Inc., Kidney, Renal Physicians Association, Reading, BPS Barbara Wilson Lifetime Achievement Award, ISCB Senior Scientist Award, Vascular access, UCLA, Therapy, Conference, Chronic kidney disease, Kidney disease, Award, Fistula, Medical device, Pharmaceutical industry, Medicine

OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board. The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor. PatenSee is developing a contactless imaging system to provide rapid vascular access monitoring for hemodialysis patients.

Key Points: 
  • OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board.
  • The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor.
  • I am delighted to join PatenSee as the chairperson of its Scientific Advisory Board and look forward to guiding this technology's further development to rapidly make it available for improving patient outcomes," said Dr. Lok.
  • Dr. Nissenson currently serves on the Board of Directors of Elicio Therapeutics, Rockwell Medical, Innocura Nephrology and Diality Inc.

Fresenius Medical Care Partners with Sarah Bush Lincoln to Provide Life-Sustaining Care to Rural Patients

Retrieved on: 
Wednesday, August 9, 2023
Insurance, Fresenius Medical Care, Partnership, Travel, CDN, Senior, Chronic kidney disease, Atmosphere, Renal Physicians Association, Frankfurt Stock Exchange, Decontamination, All rights reserved, MBA, Rehabilitation, BSN, Dialysis, Hospital, Patient, NxStage, Nursing, Kidney, Sarah Bush Lincoln, RN, FMS, Bleeding, Environment, FME, Medical device

WALTHAM, Mass., Aug. 9, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has launched an on-site dialysis program with Sarah Bush Lincoln, a regional health system in Mattoon, IL. This program now provides dialysis services with the NxStage VersiHD home hemodialysis system to patients in the local community who previously had to travel 100 miles to receive care. By keeping patients at the local hospital, the doctors and nurses have visibility to all other diagnostics and treatments.

Key Points: 
  • When Sarah Bush Lincoln first implemented the NxStage VersiHD in partnership with Fresenius Medical Care in September of 2022, they quickly discovered their dialysis volumes grew significantly higher than anticipated, resulting in several hundred treatments thus far.
  • Fresenius Medical Care, the triangle logo, NxStage, and Versi are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies.
  • Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
  • Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

Familiarity with GSK's Jesduvroq® (daprodustat) Likely to Be Strong Driver of Adoption in Dialysis, According to Spherix Global Insights

Retrieved on: 
Monday, March 27, 2023
Anemia, Epoetin alfa, GSK, Chronic kidney disease, Renal Physicians Association, Food and Drug Administration, Education, Health care, Dialysis, Organization, Medicare, Nephrology, Patient, National Kidney Foundation, FDA, CKD, RealTime, Darbepoetin alfa, Dietary supplement, Pharmaceutical industry, Amgen

EXTON, Pa., March 27, 2023 /PRNewswire/ -- In the 32nd wave of ongoing tracking of the U.S. Renal Anemia market, Spherix surveyed 207 US nephrologists about overall patient management and anticipated treatment changes in the dialysis setting with the launch of GSK's novel HIF-PH inhibitor, Jesduvroq. The survey was fielded in March 2023.

Key Points: 
  • According to Spherix Global Insights, the latest findings from RealTime Dynamix™: Renal Anemia report indicate that the more familiar nephrologists are with Jesduvroq, the more bullish they are about uptake.
  • Spherix Global Insights' latest publication, RealTime Dynamix: Renal Anemia shows that the more familiar nephrologists are with Jesduvroq, the more favorable their impressions of the drug and the more readily they anticipate adoption.
  • Brand Adoption: Those with high familiarity are 6-7 times as likely to prescribe the drug in the next three months compared to those with low familiarity.
  • Spherix will also be tracking key launch performance metrics – including monthly tracking and quarterly deeper quantitative-qualitative analysis through its Launch Dynamix: Jesduvroq® series, kicking off in May 2023.

U.S. Medical Management (USMM) and its family of companies announces rebranding, changes name to HarmonyCares

Retrieved on: 
Wednesday, October 26, 2022
ACO, USMM, Patient, Income, Radiology, Palliative care, Medicare, Association, CEO, Physician, Heart, Renal Physicians Association, Accountable care organization, Health insurance, TROY

TROY, Mich., Oct. 26, 2022 /PRNewswire/ -- U.S. Medical Management "USMM", a recognized leader in providing high-quality, compassionate healthcare within proven care models that support complex and fragile individuals in the home setting, has completed an extensive rebranding effort to better reflect its corporate vision, as well as convey its full continuum of home-based services to patients and care partners. At the heart of this rebranding is a change of the company name to HarmonyCares and an update to the corporate and division logos. HarmonyCares Medical Group (Visiting Physicians Association), HarmonyCares Hospice (Grace/Comfort Hospice), and HarmonyCares Home Health (Pinnacle Senior Care) division branding was also launched as part of the effort.

Key Points: 
  • At the heart of this rebranding is a change of the company name to HarmonyCares and an update to the corporate and division logos.
  • HarmonyCares Medical Group (Visiting Physicians Association), HarmonyCares Hospice (Grace/Comfort Hospice), and HarmonyCares Home Health (Pinnacle Senior Care) division branding was also launched as part of the effort.
  • For nearly 3 decades, HarmonyCares has been committed to providing community-based care to patients who most often have poor health equity and limited access to care.
  • The refreshed branding reflects HarmonyCares' dedication to accessible, affordable, high-quality care, regardless of income, provided through coordinated care entities.

Residential Hospice Acquires Comfort Hospice of St. Louis Missouri and Grace Hospice of Maumee Ohio

Retrieved on: 
Monday, August 29, 2022
Hospice, CEO, Technology, NYSE, Safety, Physician, AHN, Home, Renal Physicians Association, DME, Radiology, Quality of life, Goal, Multimedia, Allegheny Health Network, Graham Holdings, Long-term care, Association, USMM, Patient, GHG, Residential care, TROY

TROY, Mich., Aug. 29, 2022 /PRNewswire/ -- Residential Hospice, a division of Graham Healthcare Group, announced today that it has acquired Comfort Hospice of St. Louis, Missouri, and Grace Hospice of Maumee, Ohio from U.S. Medical Management. This expands the footprint of Residential Hospice into Missouri and Ohio; U.S. Medical Management will retain their hospice locations outside of St. Louis and Maumee.

Key Points: 
  • TROY, Mich., Aug. 29, 2022 /PRNewswire/ -- Residential Hospice, a division of Graham Healthcare Group, announced today that it has acquired Comfort Hospice of St. Louis, Missouri, and Grace Hospice of Maumee, Ohio from U.S. Medical Management.
  • This expands the footprint of Residential Hospice into Missouri and Ohio; U.S. Medical Management will retain their hospice locations outside of St. Louis and Maumee.
  • Acquisition of hospice locations mark entry of Michigan based Residential Hospice into Missouri and Ohio markets.
  • "With the addition of Comfort Hospice of St. Louis Missouri and Grace Hospice of Maumee Ohio, we are poised for expansion throughout the Midwest as we continue our mission of making hospice care more accessible to our communities," said Justin DeWitte, CEO of Residential Hospice.

Matthew Chance Named New CEO of USMM

Retrieved on: 
Wednesday, May 18, 2022
Health, COO, Multimedia, Patient, View, Star quality, Risk adjusted mortality rate, Association, Renal Physicians Association, Medicare, Engagement, Physician, Accountable care organization, ACO, Radiology, Health equity, DME, Rubicon, CEO, Medicine, Pharmaceutical industry, Management, Health insurance, TROY, USMM

TROY, Mich., May 18, 2022 /PRNewswire/ -- U.S. Medical Management (USMM) is pleased to announce that Matthew Chance will be joining as CEO, effective immediately. In December 2021, Rubicon Founders led a consortium of investors to acquire USMM and has embarked on a path to provide medical care in the home to every American who needs it.

Key Points: 
  • TROY, Mich., May 18, 2022 /PRNewswire/ -- U.S. Medical Management (USMM) is pleased to announce that Matthew Chance will be joining as CEO, effective immediately.
  • "I am thrilled to introduce Matthew Chance as our new CEO," said Adam Boehler, CEO of Rubicon Founders and Executive Chairman of USMM.
  • USMM can further define the standard for home-based care, and I am proud to be a part of it," said Matthew Chance, CEO of USMM.
  • Matthew Chance has focused his career helping deliver healthcare services to the most vulnerable patients in the country.Most recently as CEO of Ready Responders and as President of myNEXUS, Matthew worked to innovate in-home care models that improve health equity and access to care.

SIDM Appoints Dr. William "Bill" F. Owen, Jr., MD as Chief Strategy and Innovation Officer

Retrieved on: 
Tuesday, May 10, 2022
Brown University, Health policy, Society, Brigham and Women's Hospital, University, Chief innovation officer, Senior, Health, UN, Baxter International, University of Medicine and Dentistry of New Jersey, Diagnosis, Sidra Medical and Research Center, Renal Physicians Association, Patient, Doctor of Philosophy, Partnership, Nephrology, Government, Association, Cornell University, International Association, Coalition, Dentistry, Hospital, Internal medicine, MD, FACP, Harvard University, Congressional Record, Tufts University School of Medicine, Health Affairs, Dean, Rutgers University, SIDM, Assistant Secretary of Defense for Health Affairs, Solution, CEO, Growth, Awareness, Chancellor (education), International Association of University Presidents, Multimedia, Medical device, Medicine

ALPHARETTA, Ga., May 10, 2022 /PRNewswire/ -- The CEO of the Society to Improve Diagnosis in Medicine (SIDM), Jennie-Ward Robinson, PhD, today announces the appointment of Dr. William "Bill" F. Owen, Jr., MD, FACP as Chief Strategy and Innovation Officer.

Key Points: 
  • ALPHARETTA, Ga., May 10, 2022 /PRNewswire/ -- The CEO of the Society to Improve Diagnosis in Medicine (SIDM), Jennie-Ward Robinson, PhD, today announces the appointment of Dr. William "Bill" F. Owen, Jr., MD, FACP as Chief Strategy and Innovation Officer.
  • Dr. Owen will be responsible for organizational strategy as SIDM positions itself as a leader spurring improvement in diagnosis in medicine and reducing patient harm.
  • "With Dr. Owen, we have a proven leader and expert in the public, private, domestic, and international health sectors," said Dr. Ward-Robinson.
  • "Dr. Owen will bring innovative approaches to reducing the personal burden and costs of incorrect medical diagnoses.